75
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Diethylstilbesterol has Gender-Specific Effects on Weight Gain and Bone Development in Mice

&
Pages 1032-1042 | Received 29 Nov 2007, Accepted 21 Jan 2008, Published online: 06 Nov 2008

REFERENCES

  • Abraham, G., Paing, W. W., Kaminski, J., Joseph, A., Kohegyi, E., and Josiassen, R. C., 2003. Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: A prospective study, Am. J. Psychiat. 160 (2003), pp. 1618–1620.
  • Atsumi, K., Kushida, K., Yamazaki, K., Shimizu, S., Ohmura, A., and Inoue, T., 1999. Risk factors for vertebral fractures in renal osteodystrophy, Am. J. Kidney Dis. 33 (1999), pp. 287–293.
  • Blatt, J., Van, L. L., Weiner, T., and Sailer, S., 2003. Ovarian carinoma in an adolescent with transgenerataional exposure to diethylstilbesterol, J. Pediatr. Hematol. Oncol. 25 (2003), pp. 635–636.
  • Canadian Council on Animal Care, 1993. Guide to the care and use of experimental animals. Ottawa, ON: Canadian Council on Animal Care; 1993.
  • Chahal, H. S., and Drake, W. M., 2007. The endocrine system and ageing, J. Pathol. 211 (2007), pp. 173–180.
  • Coco, M., and Rush, H., 2000. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone, Am. J. Kidney Dis. 36 (2000), pp. 1115–1121.
  • Ealey, K. N., Fonseca, D., Archer, M. C., and Ward, W. E., 2006. Bone abnormalities in adolescent leptin-deficient mice, Regul. Peptides 136 (2006), pp. 9–13.
  • Eastell, R., and Lambert, H., 2002. Strategies for skeletal health in the elderly, Proc. Nutr. Soc. 61 (2002), pp. 173–180.
  • Fonseca, D., and Ward, W. E., 2004. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice, Bone 35 (2004), pp. 489–497.
  • Heaney, R. P., Abrams, S., Dawson-Hughes, B., Looker, S., Looker, A., Marcus, R., Matkovic, V., and Weaver, C., 2000. Peak bone mass, Osteoporosis Int. 11 (2000), pp. 985–1009.
  • Jefferson, W. N., and Newbold, R. R., 2000. Potential endocrine-modulating effects of various phytoestrogens in the diet, J. Nutr. 16 (2000), pp. 658–662.
  • Kelly, P. J., Nguyen, T., Hopper, J., Pocock, N., Sambrook, P., and Eisman, J., 1993. Changes in axial bone density with age: A twin study, J. Bone Mineral Res. 8 (1993), pp. 11–17.
  • Koh, K., Toyama, Y., Komiyama, M., Adachi, T., Fukata, H., and Mori, C., 2006. Neonatal administration of diethylstilbestrol has adverse effects on somatic cells rather than germ cells, Reprod. Toxicol. 22 (2006), pp. 746–753.
  • Krall, E. A., and Dawson-Hughes, B., 1993. Heritable and life-style determinants of bone mineral density, J. Bone Mineral Res. 8 (1993), pp. 1–9.
  • Migliaccio, S., Newbold, R. R., Bullock, B. C., Jefferson, W. J., Sutton, F. G., McLachlan, J. A., and Korach, K. S., 1996. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring, Endocrinology 137 (1996), pp. 2118–2125.
  • Migliaccio, S., Newbold, R. R., Teti, A., Jefferson, W. J., Toverud, S. U., Taranta, A., Bullock, B. C., Suggs, C. A., Spera, G., and Korach, K. S., 2000. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood, Bone 27 (2000), pp. 47–52.
  • Newbold, R. R., 2004. Lessons learned from perinatal exposure to diethylstilbestrol, Toxicol. Appl. Pharmacol. 199 (2004), pp. 142–150, .
  • Newbold, R. R., Bullock, B. C., and McLachlan, J. A., 1990. Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis, Cancer Res. 50 (1990), pp. 7677–7681.
  • Newbold, R. R., Jefferson, W. N., and Padilla-Banks, E., 2007a. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract, Reprod. Toxicol. 24 (2007a), p. 253.
  • Newbold, R. R., Jefferson, W. N., Padilla-Banks, E., and Hasean, J., 2004. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: Low versus high dose effects, Reprod. Toxicol. 18 (2004), pp. 399–406.
  • Newbold, R. R., Padilla-Banks, E., and Jefferson, W. N., 2006. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations, Endocrinology 147 (2006), pp. S11–S17.
  • Newbold, R. R., Padilla-Banks, E., Snyder, R. J., Phillips, T. M., and Jefferson, W. N., 2007b. Developmental exposure to endocrine disruptors and the obesity epidemic, Reprod. Toxicol. 23 (2007b), pp. 290–296.
  • Newbold, R. R, Padilla-Banks, E., Snyder, R. J., and Jefferson, W. N., 2005. Developmental exposure to estrogenic compounds and obesity, Birth Defects Research A Clin. Mol. Teratol. 73 (2005), pp. 478–480.
  • Newbold, R. R., Padilla-Banks, E., Snyder, R. J., and Jefferson, W. N., 2007c. Perinatal exposure to environmental estrogens and the development of obesity, Mol. Nutr. Food Res. 51 (2007c), pp. 912–917.
  • Newbold, R. R., Jefferson, W. N., Grissom, S. F., Padilla-Banks, E., Snyder, R. J., and Lobenhofer, E. K., 2007d. Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life, Mol. Carcinogen. 46 (2007d), pp. 783–796.
  • Nilsson, O., Mitchum, R. D., Schrier, L., Ferns, S. P., Barnes, K. M., Troendle, J. F., and Baron, J., 2005. Growth plate senescence is associated with loss of DNA methylation, J. Endocrinol. 186 (2005), pp. 241–249.
  • Penolazzi, L., Lambertini, E., Giordano, S., Sollazzo, V., Traina, G., del Senno, L., and Piva, R., 2004. Methylation analysis of the promoter F of estrogen receptor [alpha] gene: Effects on the level of transcription on human osteoblastic cells, J. Steroid Biochem. Mol. Biol. 91 (2004), pp. 1–9.
  • Piekarz, A. V., and Ward, W. E., 2007. Effect of neonatal exposure to genistein on bone metabolism in mice at adulthood, Pediatr. Res. 61 (2007), pp. 48–53.
  • Reeves, P. G., 1997. Components of the AIN-93 diets as improvements in the AIN-76A diet, J. Nutr. 127 (1997), pp. 838S–841S.
  • Reinwald, S., and Weaver, C. M., 2006. Soy isoflavones and bone health: A double-edged sword?, J. Nat. Prod. 69 (2006), pp. 450–459.
  • Roy, D., Palangat, M., Chen, C. W., Thomas, R. D., Colerangle, J., Atkinson, A., and Yan, Z. J., 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals, J. Toxicol. Environ. Health 50 (1997), pp. 1–29.
  • Rubin, M. M., 2007. Antenatal exposure to DES: Lessons learned. Future concerns, Obstet. Gynecol. Surg. 62 (2007), pp. 548–555.
  • Setchell, K. D. R., 2001. Soy isoflavones—Benefits and risks from nature's selective estrogen receptor modulators (SERMs), J. Am. Coll. Nutr. 20 (2001), pp. 354S–362S.
  • Setchell, K. D. R., and Lydeking-Olsen, E., 2003. Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies, Am. J. Clin. Nutr. 78 (2003), pp. 593S–609S.
  • Setchell, K. D., Zimmer-Nechemias, L., Cai, J., and Heubi, J. E., 1998. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life, Am. J. Clin. Nutr. 68 (1998), pp. 1453S–1461S.
  • Setchell, KD., Zimmer-Nechemias, L., Cai, J., and Heubi, J. E., 1997. Exposure of infants to phyto-oestrogens from soy-based infant formula, Lancet 350 (1997), pp. 23–27.
  • Ward, W. E., Piekarz, A. V., and Fonseca, D., 2007. Bone mass, bone strength, and their relationship in developing CD-1 mice, Can. J. Physiol. Pharmacol. 85 (2007), pp. 274–279.
  • Warita, K., Sugawara, T., Yue, Z. P., Tsukahara, S., Mutoh, K., Hasegawa, Y., Kitagawa, H., Mori, C., and Hoshi, N., 2006. Progression of the dose-related effects of estrogenic endocrine disruptors, an important factor in declining fertility, differs between the hypothalamo-pituitary axis and reproductive organs of male mice, J. Vet. Med. Sci. 68 (2006), pp. 1257–1267.
  • Watson, C. S., Bulayeva, N. N., Wozniak, A. L., and Alyea, R. A., 2007. Xenoestrogens are potent activators of nongenomic estrogenic responses, Steroids 72 (2007), pp. 124–134.
  • Wise, L. A., Palmer, J. R., Hatch, E. E., Troisi, R., Titus-Ernstoff, L., Herbst, A. L., Kaufman, R., Noller, K. L., and Hoover, R. N., 2007. Secondary sex ratio among women exposed to diethylstilbestrol in utero, Environ. Health Perspect. 115 (2007), pp. 1314–1319.
  • Wise, L. A., Palmer, J. R., Rowlings, K., Kaufman, R. H., Herbst, A. L., Noller, K. L., Titus-Ernstoff, L., Troisi, R., Hatch, E. E., and Robboy, S. J., 2005. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure, Obstet. Gynecol. 105 (2005), pp. 167–173.
  • Yellayi, S., Naaz, A., Szewczykowski, M. A., Sato, T., Woods, J. A., Chang, J., Segre, M., Allred, C. D., Helferich, W. G., and Cooke, P. S., 2002. The phytoestrogen genistein induces thymic and immune changes: A human health concern?, Proc. Nat. Acad. Sci. USA 99 (2002), pp. 7616–7621.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.